MAFLD: What Is It?

Houston Methodist

D. Victor

Best Practices In Managing NAFLD / NASH

MedNews Week

D. Bernstein

Pharmacologic Management of Alcohol Use Disorder

Scripps Health

R. Lee

The Fatty Liver Disease Epidemic

UPMC

M. Klinge

Updates in Management for Patients with Cirrhosis

Duke Health

R. Doshi

Alcohol Use Disorder (2024)

UCSF School of Medicine

T. Defries

Alcoholism is a Mid-brain Disease: Treat it as Such

Houston Methodist

H. Wetsman

Using Resmetirom (THR-β Agonist) in Your Practice for MASH

Scripps Health

J. Gutierrez

Evaluation and Management of the Pregnant Patient with Elevated Live…

Florida Gastroenterologic Society

M. Hernandez

End to End GI Pathology (and the Liver, Too!)

UCSF School of Medicine

J. (J. P.) Grenert

Primary Biliary Cholangitis: State of the Art in 2024

MUSC Health

K. Kowdley

MASLD for the Non-Hepatologist: Insights from ADA Guidelines

Washington University in St. Louis

K. Williams

Cutting Edge Diagnostics and Treatment for NAFLD

Northwestern Medicine Gastroenterology

M. E. Rinella, L. Van Wagner

Updates in Cholestatic Liver Disease: PBC and PSC

University of Colorado Department of Medicine

A. Kalra

MASLD Updates Early 2025

Adrian Lindsey

Cirrhosis of the Liver

Northwestern Medicine Gastroenterology

A. Castillo

New Therapy for Fatty Liver Disease

Washington University in St. Louis

K. Korenblat

Fatty Liver Disease: When to Refer?

Yale School of Medicine

Caring for the Post Liver Transplant Patient in the Primary Care Set…

University of Colorado Department of Medicine

B. Henderson, M. O'Meara

AI-assisted Digital Pathology in MASH Trials

Houston Methodist

V. Ratziu